Novartis Expands BeiGene Tie-Up To TIGIT Inhibitor In $1bn-Plus Option Deal

 
• By Brian Yang
  
NOVARTIS EXPANDS COLLABORATION WITH BEIGENE TO TIGIT ANTIBODY IN NEW DEAL • Source: Alamy

More from Deals

More from Business